Company: PolyPhotonix Ltd Competition: Improving the Health of People with Long-Term Conditions Innovation: Noctura 400 treatment for Diabetic Retinopathy Total award: £1,458,158 awarded across Phase 1, Phase 2 & Phase 3 development stages Savings to the NHS: Estimated at £1 billion per annum Product availability: Q4 2014 Overview PolyPhotonix, a bio-photonic research and development company, has developed a light therapy sl

Join for free to read